CDC7 and neoplasm: CDC7 overexpression may drive tumor proliferation in various malignancies (6–8), by suppressing DDR-mediated cell senescence and preventing DNA damage–induced apoptosis (9); overexpression has been associated with poor clinical outcomes (8, 10, 11) and may contribute to acquired resistance to chemotherapy (7, 8).